Features | Partner Sites | Information | LinkXpress
Sign In
JIB
GLOBETECH PUBLISHING
GLOBETECH PUBLISHING

Congress Presentation Highlights the 50 Most Innovative Technologies in 2013

By BiotechDaily International staff writers
Posted on 21 May 2013
Up to 85% of technologies developed globally never reach the business setting. Business personnel and investors need to closely assess the potential of a specific technology platform to determine the real market potential it has and to assess the risk-reward fundamentals.

Fifty of the most innovative technologies worldwide were recently presented at GIL (Growth, Innovation, Leadership) 013: Europe—The Global Community of Growth, Innovation, and Leadership annual congress, held in London (UK), presented by Frost & Sullivan (Palo Alto, CA, USA), an international growth consultancy firm. During the congress on May 14, 2013, Frost & Sullivan’s practice director for technical insights, Europe, Ankit A. Shukla, presented a unique research platform called “TechVision 2020: A Systematic Innovation Serendipity Engine.” This research revealed the 50 most innovative technologies set to considerably transform industries, strategies, and businesses in 2013.

The chosen technologies that were discussed at the congress extended across nine sectors--health and wellness, medical devices and imaging technology, advanced manufacturing and automation, sensors and control, materials and coatings, clean and green environment, information and communication technology, microelectronics, sustainable energy--and represent the majority of R&D and innovation activity today.

“Apart from identifying the top 50 technologies for 2013, our global technology team has identified various convergence opportunities enabled by a combination of the technologies. We believe these identified opportunities represent exciting times ahead for the multitude of industries and markets they will impact,” remarked Mr. Shukla.

Convergence opportunities can be found across various industry segments. One of the most thought-provoking ones is self-healing organs. Several years ago, this was just a topic for science fiction literature and movies; now it can be accomplished by the merging of the following technologies: carbon fibers, polymer chameleons, three-dimensional (3D) printing. The combination of these technologies will cut the amount of tissue rejection and also the presence of polymer chameleons that can be modified to self-heal in case of injuries and wear and tear.

Another example is interactive augmented reality (AR) that can be enabled for predictive remote patient monitoring. Capabilities converging in this case are information and communications technology (ICT) technologies (augmented reality; cloud computing; Big Data analytics; data visualization) and sensors (ubiquitous wireless sensor network; nanosensors and CBRNE [chemical, biologic, radiologic, nuclear, and high-yield explosives] sensors). The combination of selected ICT and sensor technologies could provide personalized disease management tools that help better manage predicted symptoms, chronic illness, and episodic acute disorders.

TechVision 2020 showcased each selected technology, carefully evaluating the potential of a given technology platform to understand the true market opportunities, while evaluating the risk-reward fundamentals. It appraises technology maturity and adoption ratings, possible year of impact and patent landscape, examines private and government funding trends, and examines future technology and application roadmaps. Furthermore, more interestingly, the output evaluated future convergence opportunities as well as the next leaps in innovation that will have a lasting impact on industries and markets.

“In order not to remain in the ‘Valley of Death,’ investors have to understand the potential of their technology and the true value it can bring. Innovative products are different; they are not in compliance with existing standards. Sometimes, revenues are not so obvious and ROI [return of investment] can take more time. The important aspect here is to educate end-users and society about the benefits innovative technology and products can bring,” summarized Mr. Shukla.

Related Links:

Frost & Sullivan
GIL 2013-Global Community of Growth, Innovation, and Leadership Congress



comments powered by Disqus

Channels

Genomics/Proteomics

view channel
Image: Alternative splicing produces two protein isoforms (Photo courtesy of Wikimedia Commons).

Key Regulator of Cancer-Inducing Alternative Splicing Identified

Cancer researchers have identified the splicing factor RBM4 (RNA-binding protein 4) as a key determinant in processes that prevent tumor development and spread. RBM4 is known to be crucial to gene splicing... Read more

Drug Discovery

view channel

Ibuprofen May Restore Immune Function in Older Individuals

New research suggests that macrophages from the lungs of old mice respond differently to infections than those of young mice, and ibuprofen given to the mice reversed these changes. New research using lab mice suggests that the solution to more youthful immune function might already be a common over-the-counter pain reliever.... Read more

Therapeutics

view channel
Image: Hair follicle (blue) being attacked by T cells (green) (Photo courtesy of Christiano Lab/Columbia University Medical Center).

Hair Restoration Method Clones Patients’ Cells to Grow New Hair Follicles

Researchers have developed of a new hair restoration approach that uses a patient’s cells to grow new hair follicles. In addition, the [US] Food and Drugs Administration (FDA) recently approved a new drug... Read more

Lab Technologies

view channel
Image: Leica Microsystems launches the inverted research microscope platform Leica DMi8 (Photo courtesy of Leica Microsystems).

New Inverted Microscope Designed to Readily Adapt to Changing Research Demands

A new inverted microscope for biotech and other life science laboratories was designed to readily accommodate modifications and upgrades to allow it to keep current with changing research demands and interests.... Read more

Business

view channel

Partnership Established to Decode Bowel Disease

23andMe (Mountain View, CA,USA), a personal genetics company, is collaborating with Pfizer, Inc. (New York, NY, USA), in which the companies will seek to enroll 10,000 people with inflammatory bowel disease (IBD) in a research project designed to explore the genetic factors associated with the onset, progression, severity,... Read more
 
Copyright © 2000-2014 Globetech Media. All rights reserved.